120 related articles for article (PubMed ID: 6990881)
21. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis.
Dixon JS; Bird HA; Sitton NG; Pickup ME; Wright V
Scand J Rheumatol; 1984; 13(1):39-44. PubMed ID: 6202005
[TBL] [Abstract][Full Text] [Related]
22. Sulphasalazine in rheumatoid arthritis.
McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
[TBL] [Abstract][Full Text] [Related]
23. Salazopyrin in rheumatoid arthritis.
McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
[TBL] [Abstract][Full Text] [Related]
24. A comparison between clinical and laboratory tests in rheumatoid arthritis.
Grindulis KA; Calverley M; Constable TJ; Forster PJ; Ahmed ME; McConkey B
Scand J Rheumatol; 1983; 12(3):285-8. PubMed ID: 6623019
[TBL] [Abstract][Full Text] [Related]
25. Outcome of rheumatoid arthritis following adjunct statin therapy.
Das S; Mohanty M; Padhan P
Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
[TBL] [Abstract][Full Text] [Related]
26. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.
Amalraj A; Varma K; Jacob J; Divya C; Kunnumakkara AB; Stohs SJ; Gopi S
J Med Food; 2017 Oct; 20(10):1022-1030. PubMed ID: 28850308
[TBL] [Abstract][Full Text] [Related]
27. Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
Murota A; Suzuki K; Kassai Y; Miyazaki T; Morita R; Kondo Y; Takeshita M; Niki Y; Yoshimura A; Takeuchi T
Cytokine; 2016 Feb; 78():87-93. PubMed ID: 26700586
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters.
Lund B; Graae A; Sonne I; Andersen RB
Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933
[TBL] [Abstract][Full Text] [Related]
29. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
Situnayake RD; McConkey B
J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
[TBL] [Abstract][Full Text] [Related]
30. Microalbuminuria in patients with rheumatoid arthritis.
Pedersen LM; Nordin H; Svensson B; Bliddal H
Ann Rheum Dis; 1995 Mar; 54(3):189-92. PubMed ID: 7748016
[TBL] [Abstract][Full Text] [Related]
31. Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.
Chard MD; Calvin J; Price CP; Cawston TE; Hazleman BL
Ann Rheum Dis; 1988 Aug; 47(8):665-71. PubMed ID: 3261967
[TBL] [Abstract][Full Text] [Related]
32. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
33. Effects of a single massive intravenous dose of hydrocortisone in rheumatoid arthritis.
Haataja M; Kalliomaki JL
Curr Ther Res Clin Exp; 1975 Jan; 17(1):80-7. PubMed ID: 806432
[No Abstract] [Full Text] [Related]
34. [Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction].
Silva I; Mateus M; Branco JC
Acta Reumatol Port; 2010; 35(5):456-62. PubMed ID: 21245814
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
36. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
Vlak T; Jajić Z
Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
[TBL] [Abstract][Full Text] [Related]
37. Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Clin Exp Rheumatol; 2006; 24(5):529-33. PubMed ID: 17181921
[TBL] [Abstract][Full Text] [Related]
38. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
Amos RS; Constable TJ; Crockson RA; Crockson AP; McConkey B
Br Med J; 1977 Jan; 1(6055):195-7. PubMed ID: 832072
[TBL] [Abstract][Full Text] [Related]
39. [The effect of an antimalarial agent (chloroquine) on acute phase reactants in patients with rheumatoid arthritis].
Jajić Z; Vuksic D; Jajić I
Reumatizam; 1994; 41(2):5-7. PubMed ID: 8693197
[TBL] [Abstract][Full Text] [Related]
40. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
Martin L; Sitar DS; Chalmers IM; Hunter T
J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
